Literature DB >> 26114651

Determination and pharmacokinetic studies of artesunate and its metabolite in sheep plasma by liquid chromatography-tandem mass spectrometry.

Bing Li1, Jie Zhang2, Xu-Zheng Zhou1, Jian-Yong Li1, Ya-Jun Yang1, Xiao-Juan Wei1, Jian-Rong Niu1, Xi-Wang Liu1, Jin-Shan Li1, Ji-Yu Zhang3.   

Abstract

A rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated to simultaneous quantify artesunate and its metabolite in sheep plasma. The plasma samples were prepared by liquid-liquid extraction. Chromatographic separation was achieved on a C18 column (250×4.6mm, 5μm) using methanol: water (60:40, v/v) (the water included 1mM ammonium acetate, 0.1% formic acid, and 0.02% acetic acid) as the mobile phase. Mass detection was carried out using positive electrospray ionization in multiple reaction monitoring mode. The calibration curve was linear from 1ng/mL to 400ng/mL (r(2)=0.9992 for artesunate, r(2)=0.9993 for its metabolite). The intra- and inter-day accuracy and precision were within the acceptable limits of ±10% at all concentrations for both artesunate and its metabolite. The recoveries ranged from 92% to 98% at the three concentrations for both. In summary, the LC-MS/MS metho described herein was fully successfully applied to pharmacokinetic studies of artesunate nanoemulsion after intramuscular delivery to sheep.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Antiparasitic; Artesunate nanoemulsion; LC/MS/MS; Pharmacokinetics; Sheep plasma

Mesh:

Substances:

Year:  2015        PMID: 26114651     DOI: 10.1016/j.jchromb.2015.05.001

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  1 in total

1.  A simple sensitive UFLC-MS/MS method for the simultaneous quantification of artesunate, dihydroartemisinin and quercetin in rat plasma and its application to pharmacokinetic studies.

Authors:  Nethravathi Puttappa; Karthik Yamjala; Narenderan S T; Suresh Kumar Raman; Gowthamarajan Kuppusamy; Basuvan Babu; P Ram Kumar
Journal:  RSC Adv       Date:  2019-12-17       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.